- Trials with a EudraCT protocol (76)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (22)
Query did not match any clinical trials.
| These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
| Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. | |
| Study title: Open, multicentre study to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ live attenuated Measles-Mumps-Rubella vaccine (PriorixTM) given to healthy children at the age of 12 to 15 months or 4- 6 years |
| Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47874 |
| Study title: Post-Marketing Surveillance Report of Priorix™ (Priorix™, Combined Measles-Mumps-Rubella vaccine) Surveillance period: (20 August 1999 ~ 19 August 2005) |
| Active substance: trivalent attenuated measles (Schwarz strain) - mumps (RIT 4385 and RIT 4386) - rubella (RA 27/3 strain) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47873 |
| Study title: Study of the live attenuated Rubella vaccine among adults (≥ 15 years old) |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47473 |
| Study title: Study of the live attenuated Rubella vaccine among children and adolescent |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 21212 |
| Study title: Vaccination with a live attenuated RA27/3 strain rubella vaccine, a follow up study |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41362 |
| Study title: Rubella vaccine in school Children |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41364 |
| Study title: Rubella vaccine in school Children |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41456 |
| Study title: A randomized, double-blind, placebo-controlled trial to measure the antibody response to immunization with measles-mumbs-rubella vaccines using EMLA patch for the reduction of pain associated with subcutaneous injection in twelve month old infants, 1998 |
| Active substance: LIDOCAINE AND PRILOCAINE |
| Study summary document link (including results): 13_DC-EMB-0001 CSR Synopsis.pdf |
| View full study record |
| Document reference: 47245 |
| Study title: A phase III, open, randomised, controlled multicentre study to evaluate the immunogenicity and safety of one dose of GlaxoSmithKline Biologicals’ combined measles-mumps-rubella-varicella vaccine (MeMuRu- OKA) given to healthy children 4 to 6 years of age previously primed with one dose of measles-mumpsrubella vaccine (either Priorix™ or M-M-R II™) in their second year of life and presumed seronegative for varicella. |
| Active substance: Live attenuated measles, mumps, rubella, varicella vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47878 |
| Study title: A phase III, open, randomized, controlled study to evaluate the immunogenicity and safety of one dose of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella vaccine (MeMuRu-OKA) given to healthy children of 4 to 6 years of age previously primed with one dose of measles-mumps-rubella vaccine (GlaxoSmithKline Biologicals’ PriorixÔ or Merck & Co.’s M-M-R IIÔ) |
| Active substance: Live attenuated measles, mumps, rubella, varicella vaccine |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47876 |
| Study title: Clinical and immunological evaluation of the live attenuated RA27/3 rubella vaccine in seronegative children and adults in Switzerland |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41359 |
| Study title: Clinical and immunological study on RA27/3 and cendehill strains of rubella vaccines during a vaccination campaign in Brittany and Mayenne in France |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41361 |
| Study title: Clinical and serological evaluation of the live attenuated RA27/3 strain rubella vaccine in a population of susceptible children in France |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41363 |
| Study title: Clinical evaluation of the live attenuated rubella vaccine, RA27/3 on seronegative children in Dakar (Senegal) |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41358 |
| Study title: Clinical study of the vaccine against rubella rudivax Italy stydy |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41366 |
| Study title: Comparative study of 3 different strains of rubella vaccines |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41360 |
| Study title: Evaluation of the side effects occuring with two RA27/3 strains of rubella vaccine in a population of schoolgirl |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41365 |
| Study title: Evaluation of the side effects occuring with two RA27/3 strains of rubella vaccine in a population of schoolgirl |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 41457 |
| Study title: Evaluation of the side effects occuring with two RA27/3 strains of rubella vaccine in a population of schoolgirls |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47475 |
| Study title: Evaluation study of the side effects occumng after two RA27/3 strains of rubella vaccines in a population of schoolgirls. |
| Active substance: LIVE RUBELLA VACCINE (RA 27/3-M STRAIN) |
| Study summary document link (including results): |
| View full study record |
| Document reference: 47476 |
